EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Phytochemicals as Emerging Antiproliferative Agents in Head and Neck Cancer: Molecular Mechanisms and Therapeutic Strategies

Livia Ramos Santiago, Estéfani Alves Asevedo, Moon Nyeo Park, Trina E Tallei, Rosy Iara Maciel de Azambuja Ribeiro, Sang-Won Shin, Bonglee Kim

Pharmacology · 2025

DOI: 10.1159/000550172 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology, 2025. Verfasst von Livia Ramos Santiago und 6 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Pathology Laboratory, Midwest Campus, Federal University of São João del-Rei, Divinopolis, Brazil. Hauptthemen laut MEDLINE: Phytochemicals, Head and Neck Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Cancer remains a leading cause of mortality worldwide, necessitating innovative therapeutic strategies beyond conventional treatments. The increasing interest in natural and synthetic antiproliferative compounds is driven by their ability to target oncogenic pathways implicated in tumor progression, metastasis, and drug resistance. This review explores the potential of bioactive phytochemicals and molecularly targeted therapies, particularly epidermal growth factor receptor (EGFR) inhibitors, in modulating cancer cell survival, proliferation, and immune evasion. A central focus is placed on the phosphoinositide 3-kinases (PI3Ks)/protein kinase B (AKT), JAK/STAT, and mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathways, which are frequently dysregulated in therapy-resistant cancers, particularly head and neck cancer. Summary: Emerging evidence suggests that phytochemicals such as curcumin, resveratrol, and flavonoids not only suppress oncogenic signaling but also enhance apoptosis, inhibit epithelial-mesenchymal transition, and regulate oxidative stress responses. Additionally, recent preclinical and clinical studies indicate that combinatorial applications of phytochemicals with targeted agents can sensitize resistant tumors to chemotherapy and immunotherapy, thereby improving therapeutic efficacy. However, a major challenge limiting the clinical translation of phytochemicals is their low bioavailability and rapid metabolism. Advances in nanoparticle-based drug delivery, synthetic derivatives, and CRISPR-mediated genome editing offer promising solutions to overcome these limitations, ensuring optimal stability, targeted delivery, and enhanced anticancer activity. Key Messages: By integrating traditional phytotherapy with modern molecular oncology, this review highlights novel synergistic strategies that may revolutionize cancer treatment, paving the way for personalized anticancer therapeutics. DBCs and herbal medicine influence key oncogenic pathways, including EGFR, PI3K/AKT, and MEK/ERK. Human papillomavirus (HPV)-positive and HPV-negative tumors exhibit distinct molecular profiles, affecting their response to conventional treatments and adjunctive therapies. Polyphenols such as curcumin, resveratrol, and quercetin, along with herbal extracts including Scutellaria baicalensis and Camellia sinensis, demonstrate the ability to modulate oxidative stress, apoptosis, and immune responses while reducing therapy resistance. Nanoparticle-based formulations improve the bioavailability of these compounds, enhancing their anticancer effects. However, their effectiveness varies based on the HPV status of the tumor, with HPV-positive cancers showing greater sensitivity to immune-modulating compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhytochemicalsHead and Neck NeoplasmsAntineoplastic Agents, PhytogenicHumansAnimalsCell ProliferationSignal TransductionMolecular Targeted Therapy

Stichwörter der Autor:innen

Antiproliferative compoundsCancer therapyDietary bioactive compoundsDrug resistanceEpidermal growth factor receptor-targeted therapyFlavonoidsHerbal medicineHuman papillomavirus-negative cancerHuman papillomavirus-positive cancerMitogen-activated protein kinase/extracellular signal-regulated kinase pathwayNanoparticle drug deliveryPhosphoinositide 3-kinases/protein kinase B pathwayPhytochemicalsPolyphenols

Substanzen

PhytochemicalsAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Experimental Pathology Laboratory, Midwest Campus, Federal University of São João del-Rei, Divinopolis, Brazil.
  • Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
  • Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Sam Ratulangi, Manado, Indonesia.
  • Department of Biology, Faculty of Medicine, Universitas Sam Ratulangi, Manado, Indonesia.
  • Department of Humanities & Social Medicine, School of Korean Medicine, Pusan National University, Yangsan-si, Republic of Korea, shinsangwon@pusan.ac.kr.
  • Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea, bongleekim@khu.ac.kr.

Zitieren

APA

Santiago, L. R., Asevedo, E. A., Park, M. N., Tallei, T. E., Maciel de Azambuja Ribeiro, R. I., Shin, S. W., & Kim, B. (2025). Phytochemicals as Emerging Antiproliferative Agents in Head and Neck Cancer: Molecular Mechanisms and Therapeutic Strategies. Pharmacology. https://doi.org/10.1159/000550172

Vancouver

Santiago LR, Asevedo EA, Park MN, Tallei TE, Maciel de Azambuja Ribeiro RI, Shin SW, et al. Phytochemicals as Emerging Antiproliferative Agents in Head and Neck Cancer: Molecular Mechanisms and Therapeutic Strategies. Pharmacology. 2025. doi:10.1159/000550172

BibTeX
@article{Santiago2025,
  author = {Santiago, Livia Ramos and Asevedo, Estéfani Alves and Park, Moon Nyeo and Tallei, Trina E and Maciel de Azambuja Ribeiro, Rosy Iara and Shin, Sang-Won and Kim, Bonglee},
  title = {Phytochemicals as Emerging Antiproliferative Agents in Head and Neck Cancer: Molecular Mechanisms and Therapeutic Strategies},
  journal = {Pharmacology},
  year = {2025},
  doi = {10.1159/000550172}
}
Kostenlos starten →